Phillip Chan is the CEO of CytoSorbents Corporation, a US-based medical device company specializing in blood purification technology. Based in Princeton, US.
Phillip Chan is the CEO of CytoSorbents Corporation, a US-based medical device company specializing in blood purification technology. Their proprietary technology, CytoSorb, is CE mark approved in the EU for cytokine removal. He is cited as a proactive shareholder, acquiring 75,188 shares of CytoSorb Corp over the last year without any sales.
Full founder directory · Investor directory · Company funding database · Fundraising library